Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Finished Goods (2018 - 2022)

AVITA Medical filings provide 5 years of Finished Goods readings, the most recent being $610000.0 for Q4 2022.

  • On a quarterly basis, Finished Goods fell 16.89% to $610000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $610000.0, a 16.89% decrease, with the full-year FY2022 number at $610000.0, down 16.89% from a year prior.
  • Finished Goods hit $610000.0 in Q4 2022 for AVITA Medical, down from $734000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $734000.0 in Q4 2021 to a low of $132212.7 in Q2 2019.
  • Median Finished Goods over the past 5 years was $354655.7 (2018), compared with a mean of $393920.7.
  • Biggest five-year swings in Finished Goods: plummeted 53.66% in 2019 and later soared 138.2% in 2021.
  • AVITA Medical's Finished Goods stood at $285311.3 in 2018, then tumbled by 53.66% to $132212.7 in 2019, then skyrocketed by 34.63% to $178000.0 in 2020, then surged by 312.36% to $734000.0 in 2021, then decreased by 16.89% to $610000.0 in 2022.
  • The last three reported values for Finished Goods were $610000.0 (Q4 2022), $734000.0 (Q4 2021), and $424000.0 (Q2 2021) per Business Quant data.